Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > The Injector
View:
Post by Year3000 on Nov 13, 2023 4:10pm

The Injector

Am I Right in thinking during the AGM Andrew was asked "will the injector only be sent off for certification if they were to win the tribunal or will it be sent off regardless?" 

i believe Andrew said it didn't matter if Replicel lost and it would still go ahead anyway. 


can somebody confirm that I'm remembering this correctly?

Comment by Ingiboy on Nov 14, 2023 11:25am
A good portion of the AGM discussed the status of the Dermal injector so it is for sure still alive. What always puzzles me is how close to submission for FDA Approval is the device.  I think for the most part  the final version is ready but it cannot be submitted for FDA Approval until the they are mass produced on an assembly line and they have not secured that yet.
Replicel Life Sciences Inc